Cargando…

Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension

PURPOSE: To prospectively investigate adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension. We also examined patient attitudes to adverse reactions via a questionnaire. METHODS: Fifty-two Japanese patients with glaucoma or ocular hypertension were enrolled. Irid...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Kenji, Shiokawa, Minako, Sugahara, Michitaka, Higa, Risako, Wakakura, Masato, Tomita, Goji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261697/
https://www.ncbi.nlm.nih.gov/pubmed/22275815
http://dx.doi.org/10.2147/OPTH.S27489
_version_ 1782221620772864000
author Inoue, Kenji
Shiokawa, Minako
Sugahara, Michitaka
Higa, Risako
Wakakura, Masato
Tomita, Goji
author_facet Inoue, Kenji
Shiokawa, Minako
Sugahara, Michitaka
Higa, Risako
Wakakura, Masato
Tomita, Goji
author_sort Inoue, Kenji
collection PubMed
description PURPOSE: To prospectively investigate adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension. We also examined patient attitudes to adverse reactions via a questionnaire. METHODS: Fifty-two Japanese patients with glaucoma or ocular hypertension were enrolled. Iridial, eyelid, and eyelash photographs were taken before and at 6 months after bimatoprost treatment. Increase in eyelid pigmentation, iridial pigmentation, eyelash growth and bristle, and vellus hair of the lid was assessed from the photographs. Questionnaires completed by patients provided insight into their subjective judgment of adverse reactions. RESULTS: Increase in eyelash bristle (53.8%), iris pigmentation (50.0%), eyelash growth (46.2%), vellus hair of the lid (40.4%), and eyelid pigmentation (7.7%) was evident after bimatoprost treatment. The objective and subjective assessments were in agreement in terms of increase in eyelash bristle, eyelash growth, and increase in vellus hair of the lid. CONCLUSION: Most patients were conscious of these adverse reactions. Before administering bimatoprost, sufficient explanation of potential adverse reactions should be provided; after initiating treatment, careful observation is required.
format Online
Article
Text
id pubmed-3261697
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32616972012-01-24 Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension Inoue, Kenji Shiokawa, Minako Sugahara, Michitaka Higa, Risako Wakakura, Masato Tomita, Goji Clin Ophthalmol Original Research PURPOSE: To prospectively investigate adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension. We also examined patient attitudes to adverse reactions via a questionnaire. METHODS: Fifty-two Japanese patients with glaucoma or ocular hypertension were enrolled. Iridial, eyelid, and eyelash photographs were taken before and at 6 months after bimatoprost treatment. Increase in eyelid pigmentation, iridial pigmentation, eyelash growth and bristle, and vellus hair of the lid was assessed from the photographs. Questionnaires completed by patients provided insight into their subjective judgment of adverse reactions. RESULTS: Increase in eyelash bristle (53.8%), iris pigmentation (50.0%), eyelash growth (46.2%), vellus hair of the lid (40.4%), and eyelid pigmentation (7.7%) was evident after bimatoprost treatment. The objective and subjective assessments were in agreement in terms of increase in eyelash bristle, eyelash growth, and increase in vellus hair of the lid. CONCLUSION: Most patients were conscious of these adverse reactions. Before administering bimatoprost, sufficient explanation of potential adverse reactions should be provided; after initiating treatment, careful observation is required. Dove Medical Press 2012 2012-01-12 /pmc/articles/PMC3261697/ /pubmed/22275815 http://dx.doi.org/10.2147/OPTH.S27489 Text en © 2012 Inoue et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Inoue, Kenji
Shiokawa, Minako
Sugahara, Michitaka
Higa, Risako
Wakakura, Masato
Tomita, Goji
Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
title Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
title_full Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
title_fullStr Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
title_full_unstemmed Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
title_short Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
title_sort iris and periocular adverse reactions to bimatoprost in japanese patients with glaucoma or ocular hypertension
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261697/
https://www.ncbi.nlm.nih.gov/pubmed/22275815
http://dx.doi.org/10.2147/OPTH.S27489
work_keys_str_mv AT inouekenji irisandperiocularadversereactionstobimatoprostinjapanesepatientswithglaucomaorocularhypertension
AT shiokawaminako irisandperiocularadversereactionstobimatoprostinjapanesepatientswithglaucomaorocularhypertension
AT sugaharamichitaka irisandperiocularadversereactionstobimatoprostinjapanesepatientswithglaucomaorocularhypertension
AT higarisako irisandperiocularadversereactionstobimatoprostinjapanesepatientswithglaucomaorocularhypertension
AT wakakuramasato irisandperiocularadversereactionstobimatoprostinjapanesepatientswithglaucomaorocularhypertension
AT tomitagoji irisandperiocularadversereactionstobimatoprostinjapanesepatientswithglaucomaorocularhypertension